Type III cyclic nucleotide phosphodiesterases and insulin action.

[1]  E. G. Loten,et al.  The antilipolytic action of insulin on adrenocorticotrophin-stimulated rat adipocytes. The roles of adenosine 3',5'-monophosphate and the protein kinase dependent on adenosine 3',5'-monophosphate. , 2005, European journal of biochemistry.

[2]  T. Uehara,et al.  Wortmannin inhibits insulin-induced Ras and mitogen-activated protein kinase activation related to adipocyte differentiation in 3T3-L1 fibroblasts. , 1995, Biochemical and biophysical research communications.

[3]  J. Tavaré,et al.  Does mitogen-activated-protein kinase have a role in insulin action? The cases for and against. , 1995, European journal of biochemistry.

[4]  J. Beavo,et al.  Multiple cyclic nucleotide phosphodiesterases. , 1994, Molecular pharmacology.

[5]  M. Ridderstråle,et al.  Essential role of phosphatidylinositol 3‐kinase in insulin‐induced activation and phosphorylation of the cGMP‐inhibited cAMP phosphodiesterase in rat adipocytes studies using the selective inhibitor wortmannin , 1994, FEBS letters.

[6]  J. Blenis,et al.  Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation , 1994, Molecular and cellular biology.

[7]  M. Taira,et al.  Identification of the phosphorylation site in vitro for cAMP-dependent protein kinase on the rat adipocyte cGMP-inhibited cAMP phosphodiesterase. , 1994, The Journal of biological chemistry.

[8]  E. Degerman,et al.  Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase. , 1994, Biochimica et biophysica acta.

[9]  T. Okada,et al.  Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. , 1994, The Journal of biological chemistry.

[10]  W. K. Sonnenburg,et al.  The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. , 1993, The Journal of biological chemistry.

[11]  V. Manganiello,et al.  Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. , 1993, The Journal of biological chemistry.

[12]  C. Crews,et al.  Extracellular signals and reversible protein phosphorylation: What to Mek of it all , 1993, Cell.

[13]  S. Elledge,et al.  Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 , 1993, Nature.

[14]  P. Warne,et al.  Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro , 1993, Nature.

[15]  J. Blenis,et al.  Signal transduction via the MAP kinases: proceed at your own RSK. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Degerman,et al.  Stimulation by insulin of a serine kinase in human platelets that phosphorylates and activates the cGMP-inhibited cAMP phosphodiesterase. , 1993, Biochemical and biophysical research communications.

[17]  Nanxin Li,et al.  The function of GRB2 in linking the insulin receptor to Ras signaling pathways. , 1993, Science.

[18]  A. Cherniack,et al.  Binding of the Ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. , 1993, Science.

[19]  M. Wigler,et al.  Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae. , 1993, The Journal of biological chemistry.

[20]  C. Lange-Carter,et al.  A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf , 1993, Science.

[21]  M. White,et al.  Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells. , 1993, The Journal of biological chemistry.

[22]  E. Nishida,et al.  The MAP kinase cascade is essential for diverse signal transduction pathways. , 1993, Trends in biochemical sciences.

[23]  M. Mclaughlin,et al.  A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA. , 1993, The Journal of biological chemistry.

[24]  J. Tavaré,et al.  Overexpression of protein kinase C isoenzymes alpha, beta I, gamma, and epsilon in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. , 1993, The Journal of biological chemistry.

[25]  E. Nishida,et al.  Phosphorylation of Xenopus mitogen-activated protein (MAP) kinase kinase by MAP kinase kinase kinase and MAP kinase. , 1993, The Journal of biological chemistry.

[26]  M. Floreani,et al.  Stimulation of rat liver microsomal cGMP-inhibited cAMP phosphodiesterase (PDE III) by phospholipase C and D. , 1993, Biochemical and biophysical research communications.

[27]  V. Manganiello,et al.  Cytosolic and sarcoplasmic reticulum-associated low Km, cGMP-inhibited cAMP phosphodiesterase in mammalian myocardium. , 1993, Biochemical and biophysical research communications.

[28]  W. K. Sonnenburg,et al.  Molecular cloning of a cDNA encoding the "61-kDa" calmodulin-stimulated cyclic nucleotide phosphodiesterase. Tissue-specific expression of structurally related isoforms. , 1993, The Journal of biological chemistry.

[29]  R. Medema,et al.  Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21ras , 1993, Molecular and cellular biology.

[30]  T. M. Roberts.  A signal chain of events , 1992, Nature.

[31]  M. Nakafuku,et al.  Function of Ras as a molecular switch in signal transduction. , 1992, The Journal of biological chemistry.

[32]  V. Arshavsky,et al.  Noncatalytic cGMP-binding sites of amphibian rod cGMP phosphodiesterase control interaction with its inhibitory gamma-subunits. A putative regulatory mechanism of the rod photoresponse. , 1992, The Journal of biological chemistry.

[33]  E. Krebs,et al.  The mitogen-activated protein kinase activator. , 1992, Current opinion in cell biology.

[34]  R. Medema,et al.  Interaction between the p21ras GTPase activating protein and the insulin receptor. , 1992, The Journal of biological chemistry.

[35]  J. Polli,et al.  Molecular cloning of DNA encoding a calmodulin-dependent phosphodiesterase enriched in striatum. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Kahn,et al.  Expression and function of IRS-1 in insulin signal transmission. , 1992, The Journal of biological chemistry.

[37]  Simeon I. Taylor,et al.  Lilly Lecture: Molecular Mechanisms of Insulin Resistance: Lessons From Patients With Mutations in the Insulin-Receptor Gene , 1992, Diabetes.

[38]  T. Pawson,et al.  SH2 and SH3 domains: From structure to function , 1992, Cell.

[39]  P. Cohen,et al.  Activation of the MAP kinase pathway by the protein kinase raf , 1992, Cell.

[40]  M. Benito,et al.  Activation of Ras by insulin in 3T3 L1 cells does not involve GTPase-activating protein phosphorylation. , 1992, The Journal of biological chemistry.

[41]  E. Nishida,et al.  Activation of mitogen-activated protein kinase and its activator by ras in intact cells and in a cell-free system. , 1992, The Journal of biological chemistry.

[42]  D. Luk,et al.  Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts , 1992, Molecular and cellular biology.

[43]  M. Pazin,et al.  Triggering signaling cascades by receptor tyrosine kinases. , 1992, Trends in biochemical sciences.

[44]  M. Conti,et al.  A polymerase chain reaction strategy to identify and clone cyclic nucleotide phosphodiesterase cDNAs. Molecular cloning of the cDNA encoding the 63-kDa calmodulin-dependent phosphodiesterase. , 1992, The Journal of biological chemistry.

[45]  W. K. Sonnenburg,et al.  Molecular cloning of cDNA encoding a "63"-kDa calmodulin-stimulated phosphodiesterase from bovine brain. , 1992, The Journal of biological chemistry.

[46]  T. Haystead,et al.  Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. , 1992, Science.

[47]  G. Hassall,et al.  Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors. , 1992, Biochemical pharmacology.

[48]  David E. Misek,et al.  An inositol phosphate glycan derived from a Trypanosoma brucei glycosyl-phosphatidylinositol mimics some of the metabolic actions of insulin. , 1992, The Journal of biological chemistry.

[49]  B. Tocqué,et al.  Stimulation of mitogen-activated protein kinase by oncogenic Ras p21 in Xenopus oocytes. Requirement for Ras p21-GTPase-activating protein interaction. , 1992, The Journal of biological chemistry.

[50]  N. Qian,et al.  Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and rat 1a cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Ullrich,et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.

[52]  R. Fischmeister,et al.  Inhibition by glucagon of the cGMP-inhibited low-Km cAMP phosphodiesterase in heart is mediated by a pertussis toxin-sensitive G-protein. , 1992, The Journal of biological chemistry.

[53]  J. Tavaré,et al.  Insulin-activated protein kinases in fat and other cells. , 1992, Biochemical Society transactions.

[54]  M. Cobb,et al.  Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[55]  David L. Brautigan,et al.  Raf-1 activates MAP kinase-kinase , 1992, Nature.

[56]  J. Flier,et al.  Relation between the insulin receptor number in cells, autophosphorylation and insulin-stimulated Ras.GTP formation. , 1992, The Journal of biological chemistry.

[57]  E. Degerman,et al.  Insulin induced phosphorylation and activation of the cGMP-inhibited cAMP phosphodiesterase in human platelets. , 1992, Biochemical and biophysical research communications.

[58]  Jonathan A. Cooper,et al.  Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. , 1992, The Journal of biological chemistry.

[59]  G. Crabtree,et al.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.

[60]  J. Bos,et al.  Involvement of p21ras in activation of extracellular signal-regulated kinase 2 , 1992, Nature.

[61]  S. Pelech,et al.  Mitogen-activated protein kinases: versatile transducers for cell signaling. , 1992, Trends in biochemical sciences.

[62]  M. Giembycz.  Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? , 1992, Biochemical pharmacology.

[63]  J. Flannery,et al.  Retinal degeneration is rescued in transgenic rd mice by expression of the cGMP phosphodiesterase beta subunit. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[64]  E. Degerman,et al.  Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[65]  L. Heasley,et al.  MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts. , 1992, The Journal of biological chemistry.

[66]  L. Lichtenstein,et al.  Preliminary identification and role of phosphodiesterase isozymes in human basophils. , 1992, Journal of immunology.

[67]  T. Roberts,et al.  Both p21ras and pp60v-src are required, but neither alone is sufficient, to activate the Raf-1 kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Corbin,et al.  Cyclic nucleotide-binding domains in proteins having diverse functions. , 1992, The Journal of biological chemistry.

[69]  J. Blenis,et al.  ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK , 1992, Cell.

[70]  Sheila M. Thomas,et al.  Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases , 1992, Cell.

[71]  E. Degerman,et al.  Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle. , 1992, Biochimica et biophysica acta.

[72]  M. White,et al.  YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[73]  R. Farese,et al.  The role of protein kinase C in insulin action. , 1992, Cellular signalling.

[74]  J. Blenis,et al.  Nuclear localization and regulation of erk- and rsk-encoded protein kinases , 1992, Molecular and cellular biology.

[75]  M. Giembycz,et al.  Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[76]  M. Mclaughlin,et al.  Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast. , 1992, The Journal of biological chemistry.

[77]  P. Blackshear,et al.  Evidence that extracellular signal-regulated kinases are the insulin-activated Raf-1 kinase kinases. , 1992, The Journal of biological chemistry.

[78]  S. Clarke,et al.  In vivo differential prenylation of retinal cyclic GMP phosphodiesterase catalytic subunits. , 1992, The Journal of biological chemistry.

[79]  G. Thomas.  MAP kinase by any other name smells just as sweet , 1992, Cell.

[80]  R. Davis,et al.  A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. , 1991, The Journal of biological chemistry.

[81]  S. E. Sadler.  Inhibitors of phosphodiesterase III block stimulation of Xenopus laevis oocyte ribosomal S6 kinase activity by insulin-like growth factor-I. , 1991, Molecular endocrinology.

[82]  S. E. Sadler.  Type III phosphodiesterase plays a necessary role in the growth-promoting actions of insulin, insulin-like growth factor-I, and Ha p21ras in Xenopus laevis oocytes. , 1991, Molecular endocrinology.

[83]  James R. Woodgett,et al.  Phosphorylation of c-jun mediated by MAP kinases , 1991, Nature.

[84]  W. Baehr,et al.  Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[85]  T. Soderling,et al.  Effects of okadaic acid on insulin-sensitive cAMP phosphodiesterase in rat adipocytes. Evidence that insulin may stimulate the enzyme by phosphorylation. , 1991, The Journal of biological chemistry.

[86]  W. K. Sonnenburg,et al.  Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants. , 1991, The Journal of biological chemistry.

[87]  W. Thompson,et al.  Activation of rabbit liver high affinity cAMP (type IV) phosphodiesterase by a vanadyl-glutathione complex. Characterization of the role of the sulfhydryl. , 1991, The Journal of biological chemistry.

[88]  J. Cunnick,et al.  Identification of the retinal cyclic GMP phosphodiesterase inhibitory gamma-subunit interaction sites on the catalytic alpha-subunit. , 1991, The Journal of biological chemistry.

[89]  T. Curran,et al.  Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. , 1991, The Journal of biological chemistry.

[90]  D. Blumenthal,et al.  Evidence for domain organization within the 61-kDa calmodulin-dependent cyclic nucleotide phosphodiesterase from bovine brain. , 1991, Biochemistry.

[91]  P. Cohen,et al.  Purification and characterisation of the insulin-stimulated protein kinase from rabbit skeletal muscle; close similarity to S6 kinase II. , 1991, European journal of biochemistry.

[92]  M. Conti,et al.  Hormonal regulation of cyclic nucleotide phosphodiesterases. , 1991, Endocrine reviews.

[93]  D. Blanchard,et al.  Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes. , 1991, Biochemical pharmacology.

[94]  E. Degerman,et al.  Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta. , 1991, Biochemical pharmacology.

[95]  E. Degerman,et al.  Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. Regulation of insulin- and cAMP-dependent activation by phosphorylation. , 1991, The Journal of biological chemistry.

[96]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[97]  A. Ullrich,et al.  Cytoplasmic juxtamembrane region of the insulin receptor: a critical role in ATP binding, endogenous substrate phosphorylation, and insulin-stimulated bioeffects in CHO cells. , 1991, Biochemistry.

[98]  N. Turner,et al.  Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation. , 1991, Biochemical pharmacology.

[99]  B. Undem,et al.  Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. , 1991, Thorax.

[100]  D. Stumpo,et al.  Insulin activation of protein kinase C: a reassessment. , 1991, The Journal of biological chemistry.

[101]  K. Rabe,et al.  Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan‐stimulated respiratory burst by ‘type IV’‐selective PDE inhibitors , 1991, British journal of pharmacology.

[102]  J. Blenis,et al.  Distinct mechanisms for the activation of the RSK kinases/MAP2 kinase/pp90rsk and pp70-S6 kinase signaling systems are indicated by inhibition of protein synthesis. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[103]  Nancy Y. Ip,et al.  ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF , 1991, Cell.

[104]  R. Medema,et al.  Insulin stimulation of gene expression mediated by p21ras activation. , 1991, The EMBO journal.

[105]  R. Hoult.  Cyclic nucleotide phosphodiesterases: Structure, regulation and drug action: Volume 2 of series ‘Molecular Pharmacology of Cell Regulation’; Edited by J. Beavo and M.D. Houslay; John Wiley; Chichester and New York, 1990; xii + , 1991 .

[106]  R. Erikson,et al.  Structure, expression, and regulation of protein kinases involved in the phosphorylation of ribosomal protein S6. , 1991, The Journal of biological chemistry.

[107]  U. Kaupp.  The cyclic nucleotide-gated channels of vertebrate photoreceptors and olfactory epithelium , 1991, Trends in Neurosciences.

[108]  T. Torphy,et al.  Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis. , 1991, Molecular pharmacology.

[109]  W. Kolch,et al.  Raf-1 protein kinase is required for growth of induced NIH/3T3 cells , 1991, Nature.

[110]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[111]  G. Thomas,et al.  MAP2 kinase and 70K S6 kinase lie on distinct signalling pathways , 1991, Nature.

[112]  J. Beavo,et al.  High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. , 1991, The Journal of biological chemistry.

[113]  P. Dent,et al.  The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle , 1990, Nature.

[114]  W. K. Sonnenburg,et al.  Amino acid sequence of the cyclic GMP stimulated cyclic nucleotide phosphodiesterase from bovine heart. , 1990, Biochemistry.

[115]  Tiansen Li,et al.  Retinal degeneration in the rd mouse is caused by a defect in the β subunit of rod cGMP-phosphodiesterase , 1990, Nature.

[116]  K. Yau,et al.  Primary structure and functional expression of a cyclic nucleotide-activated channel from olfactory neurons , 1990, Nature.

[117]  J. Corbin,et al.  Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. , 1990, The Journal of biological chemistry.

[118]  V. V. Gubanov,et al.  Beta-subunit of bovine rod photoreceptor cGMP phosphodiesterase. Comparison with the phosphodiesterase family. , 1990, The Journal of biological chemistry.

[119]  T. Kôno,et al.  Cell-free stimulation of the insulin-sensitive cAMP phosphodiesterase by the joint actions of ATP and the soluble fraction from insulin-treated rat liver. , 1990, Biochemical and biophysical research communications.

[120]  E. Krebs,et al.  Evidence for an epidermal growth factor-stimulated protein kinase cascade in Swiss 3T3 cells. Activation of serine peptide kinase activity by myelin basic protein kinases in vitro. , 1990, The Journal of biological chemistry.

[121]  Taylor,et al.  Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase , 1990, Molecular and cellular biology.

[122]  R. Haslam,et al.  Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. , 1990, Molecular pharmacology.

[123]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[124]  J. Beavo,et al.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. , 1990, Trends in pharmacological sciences.

[125]  H. Shibata,et al.  Stimulation of the insulin-sensitive cAMP phosphodiesterase by an ATP-dependent soluble factor from insulin-treated rat adipocytes. , 1990, Biochemical and biophysical research communications.

[126]  J. Maller,et al.  Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase , 1990, Nature.

[127]  L. Cantley,et al.  Activation of phosphatidylinositol 3-kinase by insulin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[128]  I. Simpson,et al.  Insulin, oxytocin, and vasopressin stimulate protein kinase C activity in adipocyte plasma membranes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[129]  R. Challiss,et al.  Effects of selective phosphodiesterase inhibition on cyclic AMP hydrolysis in rat cerebral cortical slices , 1990, British journal of pharmacology.

[130]  P. Cohen,et al.  Protein phosphatases come of age. , 1989, The Journal of biological chemistry.

[131]  M. Conti,et al.  The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[132]  J. Beavo,et al.  Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948. , 1989, Molecular pharmacology.

[133]  T. Kôno,et al.  Cyclic GMP-dependent stimulation of the membrane-bound insulin-sensitive cAMP phosphodiesterase from rat adipocytes. , 1989, The Journal of biological chemistry.

[134]  M. Connell,et al.  Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. , 1989, The Journal of pharmacology and experimental therapeutics.

[135]  M. Houslay,et al.  Subcellular localization and hormone sensitivity of adipocyte cyclic AMP phosphodiesterase. , 1989, The Biochemical journal.

[136]  C. S. Gal,et al.  Differential Sensitivity to Cardiotonic Drugs of Cyclic AMP Phosphodiesterases Isolated from Canine Ventricular and Sinoatrial‐Enriched Tissues , 1989, Journal of cardiovascular pharmacology.

[137]  M. Conti,et al.  Molecular cloning of rat homologues of the Drosophila melanogaster dunce cAMP phosphodiesterase: evidence for a family of genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[138]  M. Houslay,et al.  Activation and phosphorylation of the 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase by cyclic AMP-dependent protein kinase. , 1989, The Biochemical journal.

[139]  M. Wigler,et al.  Isolation and characterization of a mammalian gene encoding a high-affinity cAMP phosphodiesterase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[140]  V. Manganiello,et al.  Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes. , 1989, Molecular pharmacology.

[141]  J. Maller,et al.  A similar pool of cyclic AMP phosphodiesterase in Xenopus oocytes is stimulated by insulin, insulin-like growth factor 1, and [Val12,Thr59]Ha-ras protein. , 1989, The Journal of biological chemistry.

[142]  R. Colman,et al.  cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[143]  R. Bentley,et al.  Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. , 1988, The Journal of pharmacology and experimental therapeutics.

[144]  T. Mohandas,et al.  Hormone-sensitive lipase: sequence, expression, and chromosomal localization to 19 cent-q13.3. , 1988, Science.

[145]  T. Torphy,et al.  Inhibition of the low km cyclic AMP phosphodiesterase in intact canine trachealis by SK&F 94836: mechanical and biochemical responses. , 1988, The Journal of pharmacology and experimental therapeutics.

[146]  M. Czech,et al.  Insulin receptor signaling. Activation of multiple serine kinases. , 1988, The Journal of biological chemistry.

[147]  J. Maller,et al.  Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II , 1988, Nature.

[148]  J. Beavo,et al.  Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets. , 1988, The Journal of biological chemistry.

[149]  J. Corbin,et al.  Activation of the particulate low Km phosphodiesterase of adipocytes by addition of cAMP-dependent protein kinase. , 1988, The Journal of biological chemistry.

[150]  J. Beavo,et al.  Characterization of a bovine cone photoreceptor phosphodiesterase purified by cyclic GMP-sepharose chromatography. , 1988, The Journal of biological chemistry.

[151]  E. G. Loten,et al.  Purification of an insulin-sensitive cyclic AMP phosphodiesterase from rat liver. , 1988, European journal of biochemistry.

[152]  B. Wetzel,et al.  New cardiotonic agents--a promising approach for treatment of heart failure. , 1988, Trends in pharmacological sciences.

[153]  E. Krebs,et al.  Activation of multiple protein kinases during the burst in protein phosphorylation that precedes the first meiotic cell division in Xenopus oocytes. , 1988, The Journal of biological chemistry.

[154]  A. Saltiel,et al.  Structural and functional roles of glycosyl-phosphatidylinositol in membranes. , 1988, Science.

[155]  H. R. Kaplan,et al.  Subclasses of Cyclic AMP‐Specific Phosphodiesterase in Left Ventricular Muscle and Their Involvement in Regulating Myocardial Contractility , 1987, Circulation research.

[156]  O. Rosen.  After insulin binds. , 1987, Science.

[157]  I. Mérida,et al.  Glucose transport and antilipolysis are differentially regulated by the polar head group of an insulin-sensitive glycophospholipid. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[158]  A. Newman,et al.  Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand. , 1987, The Journal of biological chemistry.

[159]  A. Saltiel.  Insulin generates an enzyme modulator from hepatic plasma membranes: regulation of adenosine 3',5'-monophosphate phosphodiesterase, pyruvate dehydrogenase, and adenylate cyclase. , 1987, Endocrinology.

[160]  M. Houslay,et al.  The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity. , 1987, The Biochemical journal.

[161]  C. Balaban,et al.  Differential localization of calmodulin-dependent enzymes in rat brain: evidence for selective expression of cyclic nucleotide phosphodiesterase in specific neurons. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[162]  P. J. England,et al.  The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. , 1987, The Biochemical journal.

[163]  J. Redmon,et al.  Short-term feedback regulation of cAMP by accelerated degradation in rat tissues. , 1987, The Journal of biological chemistry.

[164]  D. Robertson,et al.  LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum. , 1986, Molecular pharmacology.

[165]  J. Beavo,et al.  Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[166]  R. Davis,et al.  Molecular analysis of cDNA clones and the corresponding genomic coding sequences of the Drosophila dunce+ gene, the structural gene for cAMP phosphodiesterase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[167]  J. Erlichman,et al.  Enhanced activation of cAMP-dependent protein kinase by rapid synthesis and degradation of cAMP. , 1986, The Journal of biological chemistry.

[168]  J. Beavo,et al.  Immunological identification of the major platelet low-Km cAMP phosphodiesterase: probable target for anti-thrombotic agents. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[169]  V. V. Gubanov,et al.  Cyclic GMP phosphodiesterase from bovine retina Amino acid sequence of the α‐subunit and nucleotide sequence of the corresponding cDNA , 1986 .

[170]  M. Venuti,et al.  A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties. , 1986, Molecular pharmacology.

[171]  C. Lugnier,et al.  Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. , 1986, Biochemical pharmacology.

[172]  T. K. Harden,et al.  Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells. , 1986, Molecular pharmacology.

[173]  B. Desbuquois,et al.  Acute in vivo stimulation of low-Km cyclic AMP phosphodiesterase activity by insulin in rat-liver Golgi fractions. , 1986, European journal of biochemistry.

[174]  M. Houslay,et al.  Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver. , 1986, The Biochemical journal.

[175]  E. Braunwald,et al.  New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. , 1986, The New England journal of medicine.

[176]  E. Braunwald,et al.  New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1. , 1986, The New England journal of medicine.

[177]  J. Redmon,et al.  Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis. , 1985, The Journal of biological chemistry.

[178]  G. Dhillon,et al.  cAMP-dependent protein kinase and lipolysis in rat adipocytes. III. Multiple modes of insulin regulation of lipolysis and regulation of insulin responses by adenylate cyclase regulators. , 1985, The Journal of biological chemistry.

[179]  J. Corbin,et al.  cAMP-dependent protein kinase activation lowers hepatocyte cAMP. , 1985, The Journal of biological chemistry.

[180]  J. Polson,et al.  Correlation between inhibition of a cyclic GMP phosphodiesterase and relaxation of canine tracheal smooth muscle. , 1985, Biochemical pharmacology.

[181]  V. Manganiello,et al.  Antilipolytic action of insulin: role of cAMP phosphodiesterase activation. , 1985, Endocrinology.

[182]  J A Bristol,et al.  A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity. , 1985, Journal of medicinal chemistry.

[183]  D. B. Evans,et al.  Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure. , 1984, Journal of medicinal chemistry.

[184]  F. Robinson,et al.  Effects of divalent cations on the regulation of insulin-sensitive glucose transport and cAMP phosphodiesterase in adipocytes. Insulin-like effects of divalent cations. , 1984, The Journal of biological chemistry.

[185]  P. Strålfors,et al.  Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[186]  R. Colman,et al.  Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. , 1984, Biochemistry.

[187]  H. Hidaka,et al.  Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver. , 1984, Biochemistry.

[188]  V. Manganiello,et al.  Purification and characterization of cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from calf liver. Effects of divalent cations on activity. , 1983, The Journal of biological chemistry.

[189]  M. Houslay,et al.  Insulin exerts actions through a distinct species of guanine nucleotide regulatory protein: inhibition of adenylate cyclase. , 1983, The Biochemical journal.

[190]  F. Kiechle,et al.  Phospholipid modulation of low-Km cyclic AMP phosphodiesterase activity on rat adipocyte microsomes. , 1983, Archives of biochemistry and biophysics.

[191]  V. Manganiello,et al.  Hormone-sensitive particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. Regulation of responsiveness by dexamethasone. , 1983, The Journal of biological chemistry.

[192]  M. Houslay,et al.  Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes. , 1983, The Biochemical journal.

[193]  R. Meeker,et al.  Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation. , 1983, Molecular pharmacology.

[194]  J E Gander,et al.  18O labeling of adenine nucleotide alpha-phosphoryls in platelets. Contribution by phosphodiesterase-catalyzed hydrolysis of cAMP. , 1983, The Journal of biological chemistry.

[195]  T. K. Harden,et al.  Muscarinic cholinergic receptor-mediated activation of phosphodiesterase. , 1982, Molecular pharmacology.

[196]  M. M. Appleman,et al.  Insulin-dependent and insulin-independent low Km cyclic AMP phosphodiesterase from rat adipose tissue. , 1982, The Journal of biological chemistry.

[197]  M. Mumby,et al.  Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues. , 1982, The Journal of biological chemistry.

[198]  F. Kiechle,et al.  The effect of an insulin‐sensitive chemical mediator from rat adipocytes on low K m and high K m cyclic AMP phosphodiesterase , 1981, FEBS letters.

[199]  M. Houslay,et al.  Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes. , 1981, The Biochemical journal.

[200]  P. Greengard,et al.  Cyclic GMP-specific, high affinity, noncatalytic binding sites on light-activated phosphodiesterase. , 1980, The Journal of biological chemistry.

[201]  J. Corbin,et al.  Proteolytic solubilization and modification of hormone-sensitive cyclic nucleotide phosphodiesterase. , 1980, The Journal of biological chemistry.

[202]  J. Jordan,et al.  Characterization of insulin-sensitive phosphodiesterase in fat cells. I. Effects of salts and oxidation-reduction agents. , 1980, The Journal of biological chemistry.

[203]  H. Makino,et al.  Characterization of insulin-sensitive phosphodiesterase in fat cells. II. Comparison of enzyme activities stimulated by insulin and by isoproterenol. , 1980, The Journal of biological chemistry.

[204]  T. Lincoln,et al.  Characterization of a novel cGMP binding protein from rat lung. , 1980, The Journal of biological chemistry.

[205]  V. Manganiello,et al.  Purification and characterization of phosphodiesterase activator from kidney. A lysosomal protease. , 1979, The Journal of biological chemistry.

[206]  H. Hidaka,et al.  Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation. , 1979, The Journal of pharmacology and experimental therapeutics.

[207]  F. Assimacopoulos-Jeannet,et al.  Stimulation of a low Km phosphodiesterase from liver by insulin and glucagon. , 1978, The Journal of biological chemistry.

[208]  V. Manganiello,et al.  Solubilization and characterization of hormone- responsive phosphodiesterase activity of rat fat cells. , 1977, Biochimica et biophysica acta.

[209]  F. Vega,et al.  Actions of insulin in fat cells. Effects of low temperature, uncouplers of oxidative phosphorylation, and respiratory inhibitors. , 1977, The Journal of biological chemistry.

[210]  R. A. Johnson,et al.  Hormonal control of cyclic 3':5'-AMP levels and gluconeogenesis in isolated hepatocytes from fed rats. , 1975, The Journal of biological chemistry.

[211]  J. Sneyd,et al.  An effect of glucagon on 3', 5'-cyclic AMP phosphodiesterase activity in isolated rat hepatocytes. , 1975, Biochemical and biophysical research communications.

[212]  W. Thompson,et al.  Cyclic nucleotide phosphodiesterase activities from isolated fat cells: correlation of subcellular distribution with effects of nucleotides and insulin. , 1974, Archives of biochemistry and biophysics.

[213]  L. G. Pawlson,et al.  Effects of epinephrine, adrenocorticotrophic hormone, and theophylline on adenosine 3', 5'-monophosphate phosphodiesterase activity in fat cells. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[214]  B. Zinman,et al.  Effect of insulin and lipolytic agents on rat adipocyte low Km cyclic adenosine 3':5'-monophosphate phosphodiesterase. , 1974, The Journal of biological chemistry.

[215]  T. Kôno,et al.  Effects of insulin on the levels of adenosine 3':5'-monophosphate and lipolysis in isolated rat epididymal fat cells. , 1973, The Journal of biological chemistry.

[216]  V. Manganiello,et al.  An effect of insulin on cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in fat cells. , 1973, Journal of Biological Chemistry.

[217]  P. Cuatrecasas,et al.  Modulation of Adenylate Cyclase Activity in Liver and Fat Cell Membranes by Insulin , 1972, Science.

[218]  R. Renner,et al.  Insulin action on the adenyl cyclase system: Antagonism to activation by lipolytic hormones , 1972, FEBS letters.

[219]  E. G. Loten,et al.  An effect of insulin on adipose-tissue adenosine 3':5'-cyclic monophosphate phosphodiesterase. , 1970, The Biochemical journal.

[220]  R. Butcher,et al.  Role of adenosine 3',5'-monophosphate in the effects of insulin and anti-insulin serum on liver metabolism. , 1968, The Journal of biological chemistry.

[221]  R. Butcher,et al.  Effect of insulin on adenosine 3',5'-monophosphate in the rat epididymal fat pad. , 1966, The Journal of biological chemistry.

[222]  V. Manganiello,et al.  Roles of ATP in insulin actions. , 1994, Annual review of physiology.

[223]  I. Hall,et al.  Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses. , 1993, British journal of clinical pharmacology.

[224]  W. Colucci.  Search for an Effective and Safe Orally Active Positive Inotropic Drug for Treatment of Heart Failure , 1993 .

[225]  R. Denton,et al.  Characterization of the cyclic nucleotide phosphodiesterase isoenzymes present in rat epididymal fat cells. , 1992, Cellular signalling.

[226]  J. Lawrence,et al.  Signal transduction and protein phosphorylation in the regulation of cellular metabolism by insulin. , 1992, Annual review of physiology.

[227]  D. Morrison,et al.  The role of Raf-1 phosphorylation in signal transduction. , 1992, Advances in cancer research.

[228]  W. Thompson.  Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. , 1991, Pharmacology & therapeutics.

[229]  R. Challiss,et al.  Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. , 1991, TIPS - Trends in Pharmacological Sciences.

[230]  M. Nakafuku,et al.  Structure and function of signal-transducing GTP-binding proteins. , 1991, Annual review of biochemistry.

[231]  E. Degerman,et al.  Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[232]  T. Li,et al.  Bovine cone photoreceptor cGMP phosphodiesterase structure deduced from a cDNA clone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[233]  Susan S. Taylor,et al.  cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. , 1990, Annual review of biochemistry.

[234]  R. Davis,et al.  Rat homologs of the Drosophila dunce gene code for cyclic AMP phosphodiesterases sensitive to rolipram and RO 20-1724. , 1990, Molecular pharmacology.

[235]  W. K. Sonnenburg,et al.  Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[236]  A. Edelman,et al.  Protein serine/threonine kinases. , 1987, Annual review of biochemistry.